Cannabis supply


Cannabis is evolving from an outlawed narcotic, a drug fought fiercely for many years, into a valuable medicine for a number of serious diseases. In addition, the first countries (Canada, Luxembourg and several US states) have legalised the use of cannabis.

EPC HealthCare is supporting this exciting market development in close cooperation with the associated institute TakeCare GmbH. Both companies focus on different areas in the cannabis market.

EPC HealthCare advises companies on market access and strategic orientation when entering the cannabis market. This includes all relevant market segments from narcotics to food supplements laws.

The institute TakeCare focuses on market observation, questions of supply situation and access to the cannabis market for patients. It publishes market research reports on various topics. In addition, it publishes the MONITOR Cannabis in Germany and – together with INSIGHT Health GmbH the report “Cannabis market in Germany”.

stock-photo-medical-cannabis-oil-cbd-1070417192.jpg/